NEW YORK, NY / ACCESS Newswire / September 8, 2025 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/altimmune-inc-lawsuit-submission-form-2?prid=165948&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

NEW YORK, NY / ACCESS Newswire / September 8, 2025 / If you suffered a loss on your Nutex Health Inc. (NASDAQ:NUTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=165947&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 8, 2025 / If you suffered a loss on your Lineage, Inc. (NASDAQ:LINE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lineage-inc-lawsuit-submission-form?prid=165951&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / September 8, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=165952&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 8, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=165950&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 8, 2025 / If you suffered a loss on your Alto Neuroscience, Inc. (NYSE:ANRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=165949&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 8, 2025 / Trust is the currency that drives consumer markets. A brand may spend millions on advertising, packaging, and influencer campaigns, but ultimately, it’s proof that keeps customers coming back. Proof that a product is authentic. Proof that it is safe. Proof that it was made

Equities analyst Dan Ives is joining a company focused on accumulating %Worldcoin (CRYPTO: $WLD), the crypto associated with Sam Altman’s biometric identity start-up company called World. %Eightco Holdings (NASDAQ: $OCTO) has announced that Ives, Wedbush Securities’ global head of technology research, is now chair of its board of directors. Eightco also announced a $250 million

DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) — In the rapidly evolving world of financial technology, two globally renowned experts–Professor Thomas M. Ashcroft and Mike Webster–are spearheading a transformation in quantitative trading and intelligent investing with their exceptional expertise and innovative vision. As key figures at Eco Market Business Academy (EB), these industry titans have not

New York, Sept. 09, 2025 (GLOBE NEWSWIRE) — For the second time, Roger Federer teams up with Switzerland Tourism (ST) to highlight the beauty of autumn in Switzerland, in what marks their fifth campaign together. This year, Federer invites an internationally renowned American actor to join him in celebrating the beauty of autumn in Switzerland.